Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J Educ Health Promot ; 12: 351, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-38144026

RESUMO

BACKGROUND: Psychological stress is a familiar occurrence as it is linked with a sense of lack of control when up fronted with uncertainty. The study examines the mindful self-care practices of health educators and professionals in various domains and determines their relationship to the self-perceived level of mental well-being. MATERIALS AND METHODS: The study employs the quantitative descriptive approach. It was conducted in the Hail region in the academic year 2020-2021 and was participated by 91 respondents from various colleges. Self-care practices and mental well-being of health educators and professionals were determined using the Mindful Self-Care Scale and the Warwick Edinburgh Mental Well-being Scale. Pearson correlation (2-tailed) was performed to assess the significant relationship between self-care behavior and mental well-being. Post-hoc test for correlation was conducted between the mean rating for each variable for self-care behavior and the mean rating for mental well-being. This was tested at an appropriate probability value of 0.01 and 0.05. RESULTS: The overall mean for self-care behaviors of the respondents was 3.96 (SD 0.81) while the overall mental well-being score was 51.90 (SD 8.0). This was considered as average mental well-being, not indicative of possible/clinical depression. A significant relationship exists between the overall rating for self-care behavior and the overall rating for mental well-being (r = 0.661, P value < 0.001). Furthermore, with a correlation score of 0.661, the two variables have a moderately strong and significant positive relationship. CONCLUSIONS: The study affirmed the relationship between mindful self-care behaviors and mental well-being. Engaging in self-care practices regularly and frequently can develop one's well-being.

2.
Rev. esp. sanid. penit ; 21(2): 94-101, 2019. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-186862

RESUMO

Objetivos: Evaluar el uso de los tratamientos antipsicóticos prescritos en la población reclusa española y determinar si hay diferencias, en cuanto a eficacia y coste, entre los diferentes antipsicóticos inyectables de larga duración (ALD). Material y método: Estudio observacional, retrospectivo, efectuado en doce centros penitenciarios (CCPP) y en dos hospitales psiquiátricos penitenciarios. Para evaluar la eficacia, se revisaron todas las historias clínicas de pacientes con algún ALD y se seleccionaron los que estaban en situación de estabilidad terapéutica, definida como aquellos tratamientos que no habían experimentado ningún cambio en los tres últimos meses, tanto en dosis como en la asociación de otro antipsicótico. Resultados: De 11.953 internos incluidos, 1.851 (el 15,5%) tenían prescrito algún antipsicótico; 415 (el 87%) en los hospitales psiquiátricos penitenciarios y 1.436 (el 12%) en los CCPP. La paliperidona es el ALD más prescrito en hospitales psiquiátricos penitenciarios y en CCPP, seguido del aripiprazol, el zuclopentixol y la risperidona. La flufenazina, la olanzapina y la paliperidona trimestral están poco prescritos. El 41% de los pacientes eran tratados con monoterapia y el 59% con politerapia. Con los ALD de más reciente incorporación, se ha observado una tendencia a la disminución de la politerapia. Discusión: La prevalencia de prescripción de ALD en población reclusa es muy superior a la de la población no presa. La politerapia está muy extendida, aunque muestra una tendencia descendente con el uso de los fármacos más recientemente comercializados. Se recomienda que además de la eficacia terapéutica se valore a la hora de prescribir el riesgo de interacciones farmacológicas y el coste del tratamiento


Objective: To assess the use of prescribed antipsychotic treatments in the Spanish prison population in order to determine whether there are differences in efficacy and cost between the different long-acting antipsychotic injectables (LAIs). Material and method: An observational, retrospective study was carried out in twelve prisons and in two prison psychiatric hospitals. To assess efficacy, all the clinical histories of patients with some kind of LAI were reviewed and only those who were in a situation of therapeutic stability were selected, defined as those treatments that had not undergone any change in the three last months, both in doses and in the association of another antipsychotic. Results: Of the 11,953 inmates included in the study, 1,851 (15.5%) received prescriptions for an antipsychotic, 415 in penitentiary psychiatric hospitals (87%) and 1,436 in prisons (12%), which is a much higher prevalence than that found in the population. Regarding the prescription pattern of LAIs, paliperidone is the most widely prescribed in prison psychiatric hospitals and prisons, followed by aripiprazole, zuclopenthixol and risperidone. Finally flufenazine, olanzapine and paliperidone quarterly, which are scarcely represented. Of the 292 patients with LAI, 41% (121 patients) are with monotherapy and 59% (171 patients) are with polytherapy, which is similar to the data found in the bibliography. Discussion: The use of prescribed LAIs amongst inmates is widespread. Polytherapy is also a common phenomenon, although there is a downward trend due to the use of more recently marketed drugs. Since the use of LAI is long-term, with numerous side effects and a wide range of prices, it is essential to consider the patient's risk factors and the cost of treatment alongside the therapeutic efficacy


Assuntos
Humanos , Masculino , Feminino , Adulto , Antipsicóticos/administração & dosagem , Conduta do Tratamento Medicamentoso/organização & administração , Esquizofrenia/tratamento farmacológico , Transtornos Psicóticos/tratamento farmacológico , Prisioneiros/estatística & dados numéricos , Injeções/estatística & dados numéricos , Quimioterapia Combinada/estatística & dados numéricos , Prescrições de Medicamentos/estatística & dados numéricos , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA